Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $31.5700 (-0.5%) ($31.5700 - $31.5700) on Thu. May. 13, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.64% (three month average) | RSI | 32 | Latest Price | $31.5700(-0.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -8.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IBUY(59%) IWC(59%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.32% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-13%) TBT(-6%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.32% (StdDev 4.64%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $18.97(-39.91%) | Resistance Level | $35.11 | 5 Day Moving Average | $32.34(-2.38%) | 10 Day Moving Average | $33.64(-6.15%) | 20 Day Moving Average | $35.11(-10.08%) | To recent high | -44% | To recent low | 0.7% | Market Cap | $1.961b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |